nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP2D6—Vinorelbine—ovarian cancer	0.115	0.255	CbGbCtD
Hydrocodone—CYP3A4—Topotecan—ovarian cancer	0.104	0.23	CbGbCtD
Hydrocodone—CYP3A4—Vinorelbine—ovarian cancer	0.0731	0.162	CbGbCtD
Hydrocodone—CYP3A4—Paclitaxel—ovarian cancer	0.0514	0.114	CbGbCtD
Hydrocodone—CYP2D6—Doxorubicin—ovarian cancer	0.0436	0.0964	CbGbCtD
Hydrocodone—CYP3A4—Docetaxel—ovarian cancer	0.0372	0.0822	CbGbCtD
Hydrocodone—CYP3A4—Doxorubicin—ovarian cancer	0.0277	0.0613	CbGbCtD
Hydrocodone—Naloxone—TLR4—ovarian cancer	0.0106	0.572	CrCbGaD
Hydrocodone—Naloxone—ESR1—ovarian cancer	0.00298	0.16	CrCbGaD
Hydrocodone—Arthralgia—Vinorelbine—ovarian cancer	0.00193	0.00364	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00193	0.00364	CcSEcCtD
Hydrocodone—Dyspnoea—Topotecan—ovarian cancer	0.00193	0.00364	CcSEcCtD
Hydrocodone—Abdominal pain—Chlorambucil—ovarian cancer	0.00192	0.00362	CcSEcCtD
Hydrocodone—Body temperature increased—Chlorambucil—ovarian cancer	0.00192	0.00362	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00191	0.00361	CcSEcCtD
Hydrocodone—Paraesthesia—Melphalan—ovarian cancer	0.0019	0.00359	CcSEcCtD
Hydrocodone—Urinary tract infection—Paclitaxel—ovarian cancer	0.00189	0.00358	CcSEcCtD
Hydrocodone—Dyspnoea—Melphalan—ovarian cancer	0.00189	0.00356	CcSEcCtD
Hydrocodone—Neck pain—Doxorubicin—ovarian cancer	0.00186	0.00352	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Doxorubicin—ovarian cancer	0.00186	0.00352	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00186	0.00352	CcSEcCtD
Hydrocodone—Fatigue—Topotecan—ovarian cancer	0.00186	0.00352	CcSEcCtD
Hydrocodone—Constipation—Topotecan—ovarian cancer	0.00185	0.00349	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00183	0.00345	CcSEcCtD
Hydrocodone—Fatigue—Melphalan—ovarian cancer	0.00182	0.00344	CcSEcCtD
Hydrocodone—Nervous system disorder—Vinorelbine—ovarian cancer	0.00181	0.00342	CcSEcCtD
Hydrocodone—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00181	0.00342	CcSEcCtD
Hydrocodone—Skin disorder—Vinorelbine—ovarian cancer	0.00179	0.00339	CcSEcCtD
Hydrocodone—Hypersensitivity—Chlorambucil—ovarian cancer	0.00179	0.00338	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Topotecan—ovarian cancer	0.00177	0.00333	CcSEcCtD
Hydrocodone—Asthenia—Chlorambucil—ovarian cancer	0.00174	0.00329	CcSEcCtD
Hydrocodone—Naltrexone—ABCB1—ovarian cancer	0.00174	0.0935	CrCbGaD
Hydrocodone—Hypotension—Vinorelbine—ovarian cancer	0.00173	0.00326	CcSEcCtD
Hydrocodone—Oedema peripheral—Paclitaxel—ovarian cancer	0.00172	0.00325	CcSEcCtD
Hydrocodone—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00172	0.00325	CcSEcCtD
Hydrocodone—Pruritus—Chlorambucil—ovarian cancer	0.00172	0.00324	CcSEcCtD
Hydrocodone—Abdominal pain—Topotecan—ovarian cancer	0.00171	0.00322	CcSEcCtD
Hydrocodone—Body temperature increased—Topotecan—ovarian cancer	0.00171	0.00322	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00168	0.00318	CcSEcCtD
Hydrocodone—Paraesthesia—Vinorelbine—ovarian cancer	0.00166	0.00313	CcSEcCtD
Hydrocodone—Dyspnoea—Vinorelbine—ovarian cancer	0.00165	0.00311	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.0016	0.00301	CcSEcCtD
Hydrocodone—Fatigue—Vinorelbine—ovarian cancer	0.00159	0.00301	CcSEcCtD
Hydrocodone—Hypersensitivity—Topotecan—ovarian cancer	0.00159	0.003	CcSEcCtD
Hydrocodone—Angiopathy—Paclitaxel—ovarian cancer	0.00159	0.003	CcSEcCtD
Hydrocodone—Constipation—Vinorelbine—ovarian cancer	0.00158	0.00298	CcSEcCtD
Hydrocodone—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00158	0.00298	CcSEcCtD
Hydrocodone—Hypersensitivity—Melphalan—ovarian cancer	0.00156	0.00294	CcSEcCtD
Hydrocodone—Asthenia—Topotecan—ovarian cancer	0.00155	0.00293	CcSEcCtD
Hydrocodone—Hot flush—Epirubicin—ovarian cancer	0.00155	0.00292	CcSEcCtD
Hydrocodone—Vomiting—Chlorambucil—ovarian cancer	0.00154	0.00291	CcSEcCtD
Hydrocodone—Agranulocytosis—Docetaxel—ovarian cancer	0.00154	0.00291	CcSEcCtD
Hydrocodone—Mental disorder—Paclitaxel—ovarian cancer	0.00153	0.00289	CcSEcCtD
Hydrocodone—Menopausal symptoms—Epirubicin—ovarian cancer	0.00153	0.00289	CcSEcCtD
Hydrocodone—Pruritus—Topotecan—ovarian cancer	0.00153	0.00289	CcSEcCtD
Hydrocodone—Malnutrition—Paclitaxel—ovarian cancer	0.00152	0.00288	CcSEcCtD
Hydrocodone—Asthenia—Melphalan—ovarian cancer	0.00152	0.00287	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00151	0.00285	CcSEcCtD
Hydrocodone—Pruritus—Melphalan—ovarian cancer	0.0015	0.00283	CcSEcCtD
Hydrocodone—Lethargy—Epirubicin—ovarian cancer	0.00148	0.00279	CcSEcCtD
Hydrocodone—Back pain—Paclitaxel—ovarian cancer	0.00147	0.00278	CcSEcCtD
Hydrocodone—Muscle spasms—Paclitaxel—ovarian cancer	0.00146	0.00276	CcSEcCtD
Hydrocodone—Body temperature increased—Vinorelbine—ovarian cancer	0.00146	0.00276	CcSEcCtD
Hydrocodone—Abdominal pain—Vinorelbine—ovarian cancer	0.00146	0.00276	CcSEcCtD
Hydrocodone—Oedema peripheral—Docetaxel—ovarian cancer	0.00146	0.00276	CcSEcCtD
Hydrocodone—Connective tissue disorder—Docetaxel—ovarian cancer	0.00146	0.00275	CcSEcCtD
Hydrocodone—Osteoarthritis—Epirubicin—ovarian cancer	0.00145	0.00273	CcSEcCtD
Hydrocodone—Pain in extremity—Epirubicin—ovarian cancer	0.00145	0.00273	CcSEcCtD
Hydrocodone—Nausea—Chlorambucil—ovarian cancer	0.00144	0.00272	CcSEcCtD
Hydrocodone—Hot flush—Doxorubicin—ovarian cancer	0.00143	0.0027	CcSEcCtD
Hydrocodone—Dizziness—Topotecan—ovarian cancer	0.00143	0.0027	CcSEcCtD
Hydrocodone—Tremor—Paclitaxel—ovarian cancer	0.00143	0.00269	CcSEcCtD
Hydrocodone—Affect lability—Epirubicin—ovarian cancer	0.00142	0.00269	CcSEcCtD
Hydrocodone—Migraine—Epirubicin—ovarian cancer	0.00142	0.00269	CcSEcCtD
Hydrocodone—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00142	0.00268	CcSEcCtD
Hydrocodone—Vomiting—Topotecan—ovarian cancer	0.00137	0.00259	CcSEcCtD
Hydrocodone—Mood swings—Epirubicin—ovarian cancer	0.00137	0.00259	CcSEcCtD
Hydrocodone—Lethargy—Doxorubicin—ovarian cancer	0.00136	0.00258	CcSEcCtD
Hydrocodone—Rash—Topotecan—ovarian cancer	0.00136	0.00257	CcSEcCtD
Hydrocodone—Hypersensitivity—Vinorelbine—ovarian cancer	0.00136	0.00257	CcSEcCtD
Hydrocodone—Dermatitis—Topotecan—ovarian cancer	0.00136	0.00257	CcSEcCtD
Hydrocodone—Headache—Topotecan—ovarian cancer	0.00135	0.00255	CcSEcCtD
Hydrocodone—Angiopathy—Docetaxel—ovarian cancer	0.00135	0.00254	CcSEcCtD
Hydrocodone—Vomiting—Melphalan—ovarian cancer	0.00134	0.00254	CcSEcCtD
Hydrocodone—Dehydration—Epirubicin—ovarian cancer	0.00134	0.00254	CcSEcCtD
Hydrocodone—Pain in extremity—Doxorubicin—ovarian cancer	0.00134	0.00253	CcSEcCtD
Hydrocodone—Osteoarthritis—Doxorubicin—ovarian cancer	0.00134	0.00253	CcSEcCtD
Hydrocodone—Mediastinal disorder—Docetaxel—ovarian cancer	0.00134	0.00252	CcSEcCtD
Hydrocodone—Rash—Melphalan—ovarian cancer	0.00133	0.00252	CcSEcCtD
Hydrocodone—Dermatitis—Melphalan—ovarian cancer	0.00133	0.00252	CcSEcCtD
Hydrocodone—Cough—Paclitaxel—ovarian cancer	0.00133	0.00251	CcSEcCtD
Hydrocodone—Asthenia—Vinorelbine—ovarian cancer	0.00133	0.0025	CcSEcCtD
Hydrocodone—Convulsion—Paclitaxel—ovarian cancer	0.00132	0.00249	CcSEcCtD
Hydrocodone—Migraine—Doxorubicin—ovarian cancer	0.00132	0.00249	CcSEcCtD
Hydrocodone—Affect lability—Doxorubicin—ovarian cancer	0.00132	0.00249	CcSEcCtD
Hydrocodone—Hypokalaemia—Epirubicin—ovarian cancer	0.00132	0.00248	CcSEcCtD
Hydrocodone—Pruritus—Vinorelbine—ovarian cancer	0.00131	0.00247	CcSEcCtD
Hydrocodone—Mental disorder—Docetaxel—ovarian cancer	0.0013	0.00245	CcSEcCtD
Hydrocodone—Arthralgia—Paclitaxel—ovarian cancer	0.0013	0.00245	CcSEcCtD
Hydrocodone—Myalgia—Paclitaxel—ovarian cancer	0.0013	0.00245	CcSEcCtD
Hydrocodone—Anxiety—Paclitaxel—ovarian cancer	0.00129	0.00244	CcSEcCtD
Hydrocodone—Malnutrition—Docetaxel—ovarian cancer	0.00129	0.00244	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00129	0.00243	CcSEcCtD
Hydrocodone—Nausea—Topotecan—ovarian cancer	0.00128	0.00242	CcSEcCtD
Hydrocodone—Naloxone—ABCB1—ovarian cancer	0.00127	0.0682	CrCbGaD
Hydrocodone—Dry mouth—Paclitaxel—ovarian cancer	0.00127	0.00239	CcSEcCtD
Hydrocodone—Mood swings—Doxorubicin—ovarian cancer	0.00127	0.00239	CcSEcCtD
Hydrocodone—Nausea—Melphalan—ovarian cancer	0.00126	0.00237	CcSEcCtD
Hydrocodone—Back pain—Docetaxel—ovarian cancer	0.00125	0.00236	CcSEcCtD
Hydrocodone—Dehydration—Doxorubicin—ovarian cancer	0.00124	0.00235	CcSEcCtD
Hydrocodone—Muscle spasms—Docetaxel—ovarian cancer	0.00124	0.00234	CcSEcCtD
Hydrocodone—Dizziness—Vinorelbine—ovarian cancer	0.00122	0.00231	CcSEcCtD
Hydrocodone—Nervous system disorder—Paclitaxel—ovarian cancer	0.00122	0.0023	CcSEcCtD
Hydrocodone—Hypokalaemia—Doxorubicin—ovarian cancer	0.00122	0.0023	CcSEcCtD
Hydrocodone—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00122	0.0023	CcSEcCtD
Hydrocodone—Skin disorder—Paclitaxel—ovarian cancer	0.00121	0.00228	CcSEcCtD
Hydrocodone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.0012	0.00227	CcSEcCtD
Hydrocodone—Vomiting—Vinorelbine—ovarian cancer	0.00117	0.00222	CcSEcCtD
Hydrocodone—Rash—Vinorelbine—ovarian cancer	0.00116	0.0022	CcSEcCtD
Hydrocodone—Dermatitis—Vinorelbine—ovarian cancer	0.00116	0.0022	CcSEcCtD
Hydrocodone—Hypotension—Paclitaxel—ovarian cancer	0.00116	0.00219	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00116	0.00219	CcSEcCtD
Hydrocodone—Headache—Vinorelbine—ovarian cancer	0.00116	0.00219	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00113	0.00214	CcSEcCtD
Hydrocodone—Cough—Docetaxel—ovarian cancer	0.00113	0.00213	CcSEcCtD
Hydrocodone—Insomnia—Paclitaxel—ovarian cancer	0.00112	0.00212	CcSEcCtD
Hydrocodone—Convulsion—Docetaxel—ovarian cancer	0.00112	0.00211	CcSEcCtD
Hydrocodone—Paraesthesia—Paclitaxel—ovarian cancer	0.00112	0.00211	CcSEcCtD
Hydrocodone—Drowsiness—Epirubicin—ovarian cancer	0.00111	0.0021	CcSEcCtD
Hydrocodone—Dyspnoea—Paclitaxel—ovarian cancer	0.00111	0.00209	CcSEcCtD
Hydrocodone—Somnolence—Paclitaxel—ovarian cancer	0.0011	0.00209	CcSEcCtD
Hydrocodone—Arthralgia—Docetaxel—ovarian cancer	0.0011	0.00207	CcSEcCtD
Hydrocodone—Myalgia—Docetaxel—ovarian cancer	0.0011	0.00207	CcSEcCtD
Hydrocodone—Nausea—Vinorelbine—ovarian cancer	0.0011	0.00207	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00109	0.00206	CcSEcCtD
Hydrocodone—Urinary tract infection—Epirubicin—ovarian cancer	0.00108	0.00204	CcSEcCtD
Hydrocodone—Dry mouth—Docetaxel—ovarian cancer	0.00107	0.00203	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00107	0.00203	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00107	0.00203	CcSEcCtD
Hydrocodone—Fatigue—Paclitaxel—ovarian cancer	0.00107	0.00202	CcSEcCtD
Hydrocodone—Morphine—ABCB1—ovarian cancer	0.00107	0.0576	CrCbGaD
Hydrocodone—Constipation—Paclitaxel—ovarian cancer	0.00106	0.00201	CcSEcCtD
Hydrocodone—Agranulocytosis—Epirubicin—ovarian cancer	0.00104	0.00196	CcSEcCtD
Hydrocodone—Nervous system disorder—Docetaxel—ovarian cancer	0.00103	0.00195	CcSEcCtD
Hydrocodone—Thrombocytopenia—Docetaxel—ovarian cancer	0.00103	0.00195	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—ovarian cancer	0.00103	0.00195	CcSEcCtD
Hydrocodone—Skin disorder—Docetaxel—ovarian cancer	0.00102	0.00193	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00102	0.00192	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—ovarian cancer	0.001	0.00189	CcSEcCtD
Hydrocodone—Oedema peripheral—Epirubicin—ovarian cancer	0.000985	0.00186	CcSEcCtD
Hydrocodone—Hypotension—Docetaxel—ovarian cancer	0.000984	0.00186	CcSEcCtD
Hydrocodone—Connective tissue disorder—Epirubicin—ovarian cancer	0.000983	0.00186	CcSEcCtD
Hydrocodone—Body temperature increased—Paclitaxel—ovarian cancer	0.000982	0.00186	CcSEcCtD
Hydrocodone—Abdominal pain—Paclitaxel—ovarian cancer	0.000982	0.00186	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—ovarian cancer	0.000962	0.00182	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00096	0.00181	CcSEcCtD
Hydrocodone—Insomnia—Docetaxel—ovarian cancer	0.000953	0.0018	CcSEcCtD
Hydrocodone—Paraesthesia—Docetaxel—ovarian cancer	0.000946	0.00179	CcSEcCtD
Hydrocodone—Dyspnoea—Docetaxel—ovarian cancer	0.000939	0.00177	CcSEcCtD
Hydrocodone—Somnolence—Docetaxel—ovarian cancer	0.000936	0.00177	CcSEcCtD
Hydrocodone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000916	0.00173	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—ovarian cancer	0.000912	0.00172	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000909	0.00172	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000909	0.00172	CcSEcCtD
Hydrocodone—Fatigue—Docetaxel—ovarian cancer	0.000908	0.00171	CcSEcCtD
Hydrocodone—Angiopathy—Epirubicin—ovarian cancer	0.000907	0.00171	CcSEcCtD
Hydrocodone—Mediastinal disorder—Epirubicin—ovarian cancer	0.000901	0.0017	CcSEcCtD
Hydrocodone—Constipation—Docetaxel—ovarian cancer	0.000901	0.0017	CcSEcCtD
Hydrocodone—Dextromethorphan—ABCB1—ovarian cancer	0.000899	0.0483	CrCbGaD
Hydrocodone—Asthenia—Paclitaxel—ovarian cancer	0.000892	0.00168	CcSEcCtD
Hydrocodone—Pruritus—Paclitaxel—ovarian cancer	0.000879	0.00166	CcSEcCtD
Hydrocodone—Mental disorder—Epirubicin—ovarian cancer	0.000876	0.00165	CcSEcCtD
Hydrocodone—Malnutrition—Epirubicin—ovarian cancer	0.000871	0.00164	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000861	0.00163	CcSEcCtD
Hydrocodone—Back pain—Epirubicin—ovarian cancer	0.000842	0.00159	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—ovarian cancer	0.00084	0.00159	CcSEcCtD
Hydrocodone—Muscle spasms—Epirubicin—ovarian cancer	0.000837	0.00158	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000834	0.00157	CcSEcCtD
Hydrocodone—Abdominal pain—Docetaxel—ovarian cancer	0.000833	0.00157	CcSEcCtD
Hydrocodone—Body temperature increased—Docetaxel—ovarian cancer	0.000833	0.00157	CcSEcCtD
Hydrocodone—Dizziness—Paclitaxel—ovarian cancer	0.000822	0.00155	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—ovarian cancer	0.000811	0.00153	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—ovarian cancer	0.000805	0.00152	CcSEcCtD
Hydrocodone—Vomiting—Paclitaxel—ovarian cancer	0.00079	0.00149	CcSEcCtD
Hydrocodone—Rash—Paclitaxel—ovarian cancer	0.000784	0.00148	CcSEcCtD
Hydrocodone—Dermatitis—Paclitaxel—ovarian cancer	0.000783	0.00148	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—ovarian cancer	0.000779	0.00147	CcSEcCtD
Hydrocodone—Headache—Paclitaxel—ovarian cancer	0.000779	0.00147	CcSEcCtD
Hydrocodone—Hypersensitivity—Docetaxel—ovarian cancer	0.000776	0.00147	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—ovarian cancer	0.000774	0.00146	CcSEcCtD
Hydrocodone—Cough—Epirubicin—ovarian cancer	0.00076	0.00143	CcSEcCtD
Hydrocodone—Asthenia—Docetaxel—ovarian cancer	0.000756	0.00143	CcSEcCtD
Hydrocodone—Convulsion—Epirubicin—ovarian cancer	0.000754	0.00142	CcSEcCtD
Hydrocodone—Pruritus—Docetaxel—ovarian cancer	0.000745	0.00141	CcSEcCtD
Hydrocodone—Myalgia—Epirubicin—ovarian cancer	0.000741	0.0014	CcSEcCtD
Hydrocodone—Arthralgia—Epirubicin—ovarian cancer	0.000741	0.0014	CcSEcCtD
Hydrocodone—Anxiety—Epirubicin—ovarian cancer	0.000739	0.00139	CcSEcCtD
Hydrocodone—Nausea—Paclitaxel—ovarian cancer	0.000738	0.00139	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000736	0.00139	CcSEcCtD
Hydrocodone—Dry mouth—Epirubicin—ovarian cancer	0.000725	0.00137	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—ovarian cancer	0.000703	0.00133	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—ovarian cancer	0.000698	0.00132	CcSEcCtD
Hydrocodone—Nervous system disorder—Epirubicin—ovarian cancer	0.000697	0.00132	CcSEcCtD
Hydrocodone—Dizziness—Docetaxel—ovarian cancer	0.000697	0.00132	CcSEcCtD
Hydrocodone—Thrombocytopenia—Epirubicin—ovarian cancer	0.000696	0.00131	CcSEcCtD
Hydrocodone—Skin disorder—Epirubicin—ovarian cancer	0.00069	0.0013	CcSEcCtD
Hydrocodone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000687	0.0013	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—ovarian cancer	0.000686	0.00129	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—ovarian cancer	0.000686	0.00129	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—ovarian cancer	0.000683	0.00129	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000681	0.00129	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—ovarian cancer	0.000671	0.00127	CcSEcCtD
Hydrocodone—Vomiting—Docetaxel—ovarian cancer	0.00067	0.00126	CcSEcCtD
Hydrocodone—Rash—Docetaxel—ovarian cancer	0.000664	0.00125	CcSEcCtD
Hydrocodone—Hypotension—Epirubicin—ovarian cancer	0.000664	0.00125	CcSEcCtD
Hydrocodone—Dermatitis—Docetaxel—ovarian cancer	0.000664	0.00125	CcSEcCtD
Hydrocodone—Headache—Docetaxel—ovarian cancer	0.00066	0.00125	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000647	0.00122	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—ovarian cancer	0.000645	0.00122	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000644	0.00122	CcSEcCtD
Hydrocodone—Insomnia—Epirubicin—ovarian cancer	0.000643	0.00121	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—ovarian cancer	0.000639	0.00121	CcSEcCtD
Hydrocodone—Paraesthesia—Epirubicin—ovarian cancer	0.000638	0.0012	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000636	0.0012	CcSEcCtD
Hydrocodone—Dyspnoea—Epirubicin—ovarian cancer	0.000633	0.0012	CcSEcCtD
Hydrocodone—Somnolence—Epirubicin—ovarian cancer	0.000632	0.00119	CcSEcCtD
Hydrocodone—Nausea—Docetaxel—ovarian cancer	0.000626	0.00118	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—ovarian cancer	0.000614	0.00116	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000613	0.00116	CcSEcCtD
Hydrocodone—Fatigue—Epirubicin—ovarian cancer	0.000613	0.00116	CcSEcCtD
Hydrocodone—Constipation—Epirubicin—ovarian cancer	0.000608	0.00115	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000599	0.00113	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—ovarian cancer	0.000595	0.00112	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—ovarian cancer	0.00059	0.00111	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—ovarian cancer	0.000586	0.00111	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—ovarian cancer	0.000584	0.0011	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000581	0.0011	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000568	0.00107	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—ovarian cancer	0.000567	0.00107	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—ovarian cancer	0.000562	0.00106	CcSEcCtD
Hydrocodone—Body temperature increased—Epirubicin—ovarian cancer	0.000562	0.00106	CcSEcCtD
Hydrocodone—Abdominal pain—Epirubicin—ovarian cancer	0.000562	0.00106	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000538	0.00102	CcSEcCtD
Hydrocodone—Hypersensitivity—Epirubicin—ovarian cancer	0.000523	0.000988	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—ovarian cancer	0.00052	0.000981	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—ovarian cancer	0.00052	0.000981	CcSEcCtD
Hydrocodone—Asthenia—Epirubicin—ovarian cancer	0.00051	0.000963	CcSEcCtD
Hydrocodone—Pruritus—Epirubicin—ovarian cancer	0.000503	0.000949	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—ovarian cancer	0.000484	0.000915	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—ovarian cancer	0.000472	0.000891	CcSEcCtD
Hydrocodone—Dizziness—Epirubicin—ovarian cancer	0.00047	0.000887	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—ovarian cancer	0.000465	0.000878	CcSEcCtD
Hydrocodone—Vomiting—Epirubicin—ovarian cancer	0.000452	0.000853	CcSEcCtD
Hydrocodone—Rash—Epirubicin—ovarian cancer	0.000448	0.000846	CcSEcCtD
Hydrocodone—Dermatitis—Epirubicin—ovarian cancer	0.000448	0.000845	CcSEcCtD
Hydrocodone—Headache—Epirubicin—ovarian cancer	0.000445	0.00084	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—ovarian cancer	0.000435	0.000821	CcSEcCtD
Hydrocodone—Nausea—Epirubicin—ovarian cancer	0.000422	0.000797	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—ovarian cancer	0.000418	0.000789	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—ovarian cancer	0.000414	0.000783	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—ovarian cancer	0.000414	0.000782	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—ovarian cancer	0.000412	0.000778	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—ovarian cancer	0.00039	0.000737	CcSEcCtD
